title: Structure-guided drug design: conferring selectivity among neuronal nicotinic receptor and acetylcholine-binding protein subtypes.
abstract: Neuronal nicotinic receptors, encoded by nine genes of the alpha and three of the beta type of subunits, and whose gene products assemble in distinct permutations as pentameric molecules, constitute a fertile area for structure-guided drug design. Design strategies are augmented by a wide variety of peptide, alkaloid and terpenoid toxins from various marine and terrestrial species that interact with nicotinic receptors. Also, acetylcholine-binding proteins from mollusks, as structural surrogates of the receptor that mimic its extracellular domain, provide atomic resolution templates for analysis of structure and response. Herein, we describe a structure-guided approach to nicotinic ligand design that employs crystallography of this protein as the basic template, but also takes into consideration the dynamic properties of the receptor molecules in their biological media. We present the crystallographic structures of several complexes of various agonists and antagonists that associate with the agonist site and can competitively block the action of acetylcholine. In so far as the extracellular domain is involved, we identify additional non-competitive sites at those subunit interfaces where agonists do not preferentially bind. Ligand association at these interface sites may modulate receptor function. Ligand binding is also shown by solution-based spectroscopic and spectrometric methods to affect the dynamics of discrete domains of the receptor molecule. The surrogate receptor molecules can then be employed to design ligands selective for receptor subtype through the novel methods of freeze-frame, click chemistry that uses the very structure of the target molecule as a template for synthesis of the inhibitor.
authors.affiliation: Department of Pharmacology, Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093-0657, USA. pwtaylor@ucsd.edu
authors.forename: Palmer
authors.initials: P
authors.lastname: Taylor
authors.forename: Todd T
authors.initials: TT
authors.lastname: Talley
authors.forename: Zoran
authors.initials: Z
authors.lastname: Radic'
authors.forename: Scott B
authors.initials: SB
authors.lastname: Hansen
authors.forename: Ryan E
authors.initials: RE
authors.lastname: Hibbs
authors.forename: Jian
authors.initials: J
authors.lastname: Shi
mesh_terms: D000109:Acetylcholine / Q000378:metabolism*; D000595:Amino Acid Sequence; D000818:Animals; D002352:Carrier Proteins / Q000737:chemistry* / Q000145:classification; D003460:Crystallization; D015195:Drug Design; D006801:Humans; D008969:Molecular Sequence Data; D018722:Nicotinic Agonists / Q000737:chemistry; D018733:Nicotinic Antagonists / Q000737:chemistry; D011978:Receptors, Nicotinic / Q000737:chemistry* / Q000145:classification; D013050:Spectrometry, Fluorescence